Annual Drug Patent Expirations for KERYDIN Kerydin is a drug marketed by Anacor Pharms Inc and is included in one NDA. It is available from one supplier. There are five…
The post New patent for Anacor Pharms drug KERYDIN appeared first on DrugPatentWat…
Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in two NDAs. It is available from one supplier. There are thirty-nine patents…
The post New patent for Pharmacyclics Inc drug IMBRUVICA appea…
Annual Drug Patent Expirations for HETLIOZ+LQ Hetlioz Lq is a drug marketed by Vanda Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Vanda Pharms drug HETLIOZ LQ appeared first on DrugPatentW…
Annual Drug Patent Expirations for HETLIOZ+LQ Hetlioz Lq is a drug marketed by Vanda Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Vanda Pharms drug HETLIOZ LQ appeared first on DrugPatentW…
Annual Drug Patent Expirations for KATERZIA Katerzia is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Azurity drug KATERZIA appeared first on DrugPate…
Annual Drug Patent Expirations for KATERZIA Katerzia is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Azurity drug KATERZIA appeared first on DrugPate…
Annual Drug Patent Expirations for AKYNZEO Akynzeo is a drug marketed by Helsinn Hlthcare and is included in two NDAs. It is available from one supplier. There are seventeen patents…
The post New patent for Helsinn Hlthcare drug AKYNZEO appeared first …
Annual Drug Patent Expirations for FIRVANQ+KIT Firvanq Kit is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent for Azurity drug FIRVANQ KIT appeared first on DrugPatent…
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-one…
The post New patent for Astrazeneca Ab drug BYDUREON BCISE appear…
New patent for Astrazeneca Ab drug BYDUREON BCISE Read Post »
Annual Drug Patent Expirations for AUBAGIO Aubagio is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from one supplier. There are three…
The post New patent for Sanofi Aventis drug AUBAGIO appeared first on DrugPatentW…